Title: Quantitative Imaging Biomarkers for Outcome Prediction in Lung Cancer
Presenter: Dr. Sarah Mattonen, Ph.D.
Assistant Professor, Department of Medical Biophysics
Lung cancer remains the leading cause of cancer death in Canada. More accurate risk stratification tools are needed to more accurately determine patient prognosis and aid in determining optimal treatment plans for these patients. Quantitative imaging biomarkers, known as radiomics, have the potential to provide additional information on disease prognosis that is not visible to the radiologists’ eye. This talk will describe a computer-aided risk stratification model using positron emission tomography (PET) tumour and non-tumour imaging features. These computational imaging models can assist clinicians in decision-making and allow for personalized medicine, with the goal of improving outcomes for cancer patients.
Dr. Sarah Mattonen, PhD is an Assistant Professor at Western University in the Department of Medical Biophysics with a cross-appointment in the Department of Oncology. She holds the inaugural Gerald C. Baines Research Chair for Translational Cancer Imaging at the London Regional Cancer Program and is a New Scientist at the Lawson Health Research Institute. She received her PhD in Medical Biophysics from Western University in 2016 and completed her postdoctoral training at Stanford University in the Department of Radiology in 2019. Her research interests include developing, evaluating, and translating quantitative image analysis tools to support diagnosis, treatment, and response assessment in oncology.